Kevin Kennedy's CoolcatReport.com - Giving Investors the Tools to Succeed
Free Resources
Copyright © 1998-2015 Coolcat Report. All rights reserved.
Home  |  About Us  |  Newsletters  |  Performance  |  Subscribe  |  Contact

Market Wrap

Follow us on


THE DAILY GURU

INTERVIEW: Biopharma Bets

CoolcatReport.com Publisher Kevin Kennedy talks about what's ahead for biotech and shares three emerging biotech plays: Achaogen (AKAO), XenoPort (XNPT) and Kite Pharma (KITE).

https://encrypted-tbn2.gstatic.com/images?q=tbn:ANd9GcQRYYy4zPRkRG0TXo-Dxg9ezp12-F-CkAd1tc6ftnOfUybMDi4pJQ

HULBERT ON COOLCAT REPORT

Hulbert Financial Digest, the leading independent watchdog for investment newsletters, ranks The Coolcat Explosive Small Cap Growth Stock Report, the flagship report for CoolcatReport.com, No. 3 among all newsletters for the 16 years from 1999-2015 with a gain of 517.5%, an average annual increase of 12.0%.

INVESTING TIPS

How to Pick Winners, Cut Losses

Discover the best strategies for picking winning stocks and ETFs and avoiding big losses with The Coolcat Guide to Winning Stocks and The Coolcat ABCs of ETFs.

THE DAILY GURU

INTERVIEW: Small Caps and Big Techs

CoolcatReport.com Publisher Kevin Kennedy offers some emerging ETFs, two small-cap plays, a midcap that's "a new-high machine" and fresh takes on tech stalwarts Apple and Facebook.

THE DAILY GURU

INTERVIEW: Top Picks From A Coolcat Strategy

Publisher Kevin Kennedy shares his approach and offers some stock and ETF picks in an interview with Steve Halpern of MoneyShow.com.

Buying

Monster Stocks

on Pullbacks

CoolcatReport.com Publisher Kevin Kennedy shows Forbes readers how patient investors can profit when superstar stocks take a little breather.
Read more at

RESOURCES

The Best Investing Websites

Yahoo! Finance

MSN MoneyCentral

MarketWatch

Barchart.com

StockCharts.com

Complete List

Spotlight Stocks

New Highs

Strong Volume Gainers

Stock Futures